214 related articles for article (PubMed ID: 29407767)
21. Adenosine A1 receptor potentiated glycinergic transmission in spinal cord dorsal horn of rats after peripheral inflammation.
Bai HH; Liu JP; Yang L; Zhao JY; Suo ZW; Yang X; Hu XD
Neuropharmacology; 2017 Nov; 126():158-167. PubMed ID: 28882563
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the glycinergic input to bipolar cells of the mouse retina.
Ivanova E; Müller U; Wässle H
Eur J Neurosci; 2006 Jan; 23(2):350-64. PubMed ID: 16420443
[TBL] [Abstract][Full Text] [Related]
23. Disruption of a Structurally Important Extracellular Element in the Glycine Receptor Leads to Decreased Synaptic Integration and Signaling Resulting in Severe Startle Disease.
Schaefer N; Berger A; van Brederode J; Zheng F; Zhang Y; Leacock S; Littau L; Jablonka S; Malhotra S; Topf M; Winter F; Davydova D; Lynch JW; Paige CJ; Alzheimer C; Harvey RJ; Villmann C
J Neurosci; 2017 Aug; 37(33):7948-7961. PubMed ID: 28724750
[TBL] [Abstract][Full Text] [Related]
24. Activation-Dependent Rapid Postsynaptic Clustering of Glycine Receptors in Mature Spinal Cord Neurons.
Nakahata Y; Eto K; Murakoshi H; Watanabe M; Kuriu T; Hirata H; Moorhouse AJ; Ishibashi H; Nabekura J
eNeuro; 2017; 4(1):. PubMed ID: 28197549
[TBL] [Abstract][Full Text] [Related]
25. Probing glycine receptor stoichiometry in superficial dorsal horn neurones using the spasmodic mouse.
Graham BA; Tadros MA; Schofield PR; Callister RJ
J Physiol; 2011 May; 589(Pt 10):2459-74. PubMed ID: 21486794
[TBL] [Abstract][Full Text] [Related]
26. Ubiquitination and inhibition of glycine receptor by HUWE1 in spinal cord dorsal horn.
Zhang ZY; Guo Z; Li HL; He YT; Duan XL; Suo ZW; Yang X; Hu XD
Neuropharmacology; 2019 Apr; 148():358-365. PubMed ID: 30721695
[TBL] [Abstract][Full Text] [Related]
27. Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia.
Xiong W; Cheng K; Cui T; Godlewski G; Rice KC; Xu Y; Zhang L
Nat Chem Biol; 2011 May; 7(5):296-303. PubMed ID: 21460829
[TBL] [Abstract][Full Text] [Related]
28. Ht31 peptide inhibited inflammatory pain by blocking NMDA receptor-mediated nociceptive transmission in spinal dorsal horn of mice.
Wang WT; Pan GQ; Zhang ZY; Suo ZW; Yang X; Hu XD
Neuropharmacology; 2015 Feb; 89():290-7. PubMed ID: 25312281
[TBL] [Abstract][Full Text] [Related]
29. AAV-glycine receptor α3 alleviates CFA-induced inflammatory pain by downregulating ERK phosphorylation and proinflammatory cytokine expression in SD rats.
Wang HC; Cheng KI; Tseng KY; Kwan AL; Chang LL
Mol Med; 2023 Feb; 29(1):22. PubMed ID: 36792984
[TBL] [Abstract][Full Text] [Related]
30. The chemerin receptor 23 agonist, chemerin, attenuates monosynaptic C-fibre input to lamina I neurokinin 1 receptor expressing rat spinal cord neurons in inflammatory pain.
Dickie AC; Torsney C
Mol Pain; 2014 Apr; 10():24. PubMed ID: 24716552
[TBL] [Abstract][Full Text] [Related]
31. Subunit-specific potentiation of recombinant glycine receptors by NV-31, a bilobalide-derived compound.
Lynch JW; Chen X
Neurosci Lett; 2008 Apr; 435(2):147-51. PubMed ID: 18329806
[TBL] [Abstract][Full Text] [Related]
32. Glycine receptors: a new therapeutic target in pain pathways.
Lynch JW; Callister RJ
Curr Opin Investig Drugs; 2006 Jan; 7(1):48-53. PubMed ID: 16425671
[TBL] [Abstract][Full Text] [Related]
33. Functional reconstitution of glycinergic synapses incorporating defined glycine receptor subunit combinations.
Zhang Y; Dixon CL; Keramidas A; Lynch JW
Neuropharmacology; 2015 Feb; 89():391-7. PubMed ID: 25445488
[TBL] [Abstract][Full Text] [Related]
34. Chemokine CXCL1 enhances inflammatory pain and increases NMDA receptor activity and COX-2 expression in spinal cord neurons via activation of CXCR2.
Cao DL; Zhang ZJ; Xie RG; Jiang BC; Ji RR; Gao YJ
Exp Neurol; 2014 Nov; 261():328-36. PubMed ID: 24852102
[TBL] [Abstract][Full Text] [Related]
35. Gelsemine, a principal alkaloid from Gelsemium sempervirens Ait., exhibits potent and specific antinociception in chronic pain by acting at spinal α3 glycine receptors.
Zhang JY; Gong N; Huang JL; Guo LC; Wang YX
Pain; 2013 Nov; 154(11):2452-2462. PubMed ID: 23886522
[TBL] [Abstract][Full Text] [Related]
36. Plasticity of synaptic inhibition in mouse spinal cord lamina II neurons during early postnatal development and after inactivation of the glycine receptor alpha3 subunit gene.
Rajalu M; Müller UC; Caley A; Harvey RJ; Poisbeau P
Eur J Neurosci; 2009 Dec; 30(12):2284-92. PubMed ID: 20092571
[TBL] [Abstract][Full Text] [Related]
37. GlyR alpha3: an essential target for spinal PGE2-mediated inflammatory pain sensitization.
Harvey RJ; Depner UB; Wässle H; Ahmadi S; Heindl C; Reinold H; Smart TG; Harvey K; Schütz B; Abo-Salem OM; Zimmer A; Poisbeau P; Welzl H; Wolfer DP; Betz H; Zeilhofer HU; Müller U
Science; 2004 May; 304(5672):884-7. PubMed ID: 15131310
[TBL] [Abstract][Full Text] [Related]
38. Zinc-dependent modulation of α2- and α3-glycine receptor subunits by ethanol.
McCracken LM; Trudell JR; McCracken ML; Harris RA
Alcohol Clin Exp Res; 2013 Dec; 37(12):2002-10. PubMed ID: 23895467
[TBL] [Abstract][Full Text] [Related]
39. Glycine Receptor Drug Discovery.
Lynch JW; Zhang Y; Talwar S; Estrada-Mondragon A
Adv Pharmacol; 2017; 79():225-253. PubMed ID: 28528670
[TBL] [Abstract][Full Text] [Related]
40. Glycine receptors expression in rat spinal cord and dorsal root ganglion in prostaglandin E2 intrathecal injection models.
Wang HC; Cheng KI; Chen PR; Tseng KY; Kwan AL; Chang LL
BMC Neurosci; 2018 Nov; 19(1):72. PubMed ID: 30413143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
